Literature DB >> 19477025

Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.

Maya N Hatch1, Chris S Schaumburg, Thomas E Lane, Hans S Keirstead.   

Abstract

Human embryonic stem cell-derived oligodendrocyte progenitors (OPCs) were transplanted into mice persistently infected with the neurotropic JHM strain of mouse hepatitis virus with established demyelination. Engrafted cells did not survive past 2 weeks following transplantation despite treatment with high dose cyclosporine A. While T cell infiltration into the CNS was dampened, elevated numbers of macrophage/microglia and endogenous OPCs were evident surrounding the implantation site and this was associated with increased remyelination. These data suggest that remyelination was initiated by the local response to xenograft transplantation. These findings illustrate the complexities of OPC transplantation into areas of robust immune-mediated pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477025     DOI: 10.1016/j.jneuroim.2009.05.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Cell replacement therapies to promote remyelination in a viral model of demyelination.

Authors:  Emanuele Tirotta; Kevin S Carbajal; Chris S Schaumburg; Lucia Whitman; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2010-06-02       Impact factor: 3.478

Review 2.  Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.

Authors:  Vrushali Mangale; Laura L McIntyre; Craig M Walsh; Jeanne F Loring; Thomas E Lane
Journal:  Dev Dyn       Date:  2018-09-06       Impact factor: 3.780

3.  Two-photon imaging of cellular dynamics in the mouse spinal cord.

Authors:  Jason G Weinger; Milton L Greenberg; Melanie P Matheu; Ian Parker; Craig M Walsh; Thomas E Lane; Michael D Cahalan
Journal:  J Vis Exp       Date:  2015-02-22       Impact factor: 1.355

Review 4.  Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives.

Authors:  Walaa F Alsanie; Jonathan C Niclis; Steven Petratos
Journal:  Stem Cells Dev       Date:  2013-06-12       Impact factor: 3.272

Review 5.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

6.  ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.

Authors:  Heechul Kim; Piotr Walczak; Naser Muja; James T Campanelli; Jeff W M Bulte
Journal:  Glia       Date:  2012-04-12       Impact factor: 7.452

7.  Variation in Anti-inflammatory, Anti-arthritic, and Antimicrobial Activities of Different Extracts of Common Egyptian Seaweeds with an Emphasis on Their Phytochemical and Heavy Metal Contents.

Authors:  Aida H Shobier; Mona M Ismail; Sahar W M Hassan
Journal:  Biol Trace Elem Res       Date:  2022-06-04       Impact factor: 3.738

8.  Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Mohammad Mardani; Ebrahim Esfandiari; Hossein Salehi; Sayyed Hamid Zarkesh Esfahani
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

Review 9.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

10.  Study on the Safety of Human Oligodendrocyte Precursor Cell Transplantation in Young Animals and Its Efficacy on Myelination.

Authors:  Haipeng Zhou; Siliang Lu; Ke Li; Yinxiang Yang; Caiyan Hu; Zhaoyan Wang; Qian Wang; Ying He; Xiaohua Wang; Dou Ye; Qian Guan; Jing Zang; Chang Liu; Suqing Qu; Zuo Luan
Journal:  Stem Cells Dev       Date:  2021-04-29       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.